Literature DB >> 3782261

Carcinogenesis in F-344 rats induced by nitrosohydroxyalkyl-chloroethylureas.

W Lijinsky, R M Kovatch, S S Singer.   

Abstract

The two isomeric N-nitroso derivatives of 1-chloroethyl-3-(2-hydroxyethyl)-urea and of 1-chloroethyl-3-(2-hydroxypropyl)-urea were prepared and isolated. They were given by gavage in ethyl acetate/corn oil to groups of 20 male and female F-344 rats. The two nitroso-1-chloroethyl compounds were nephrotoxic and most animals died within 20 weeks; no neoplasms were seen in any of these animals. Nitroso-1-hydroxyethyl-3-chloroethylurea was given at 2 concentrations, 21 and 10.5 mg/ml; in both groups almost all animals died with neoplasms related to the treatment. These included hepatocellular and cholangiocellular neoplasms of the liver; many of the former metastasized. Many rats also had tubular cell neoplasms in the kidney. Nitroso-1-(2-hydroxypropyl)-3-chloroethylurea was a less potent carcinogen at equimolar doses, inducing fewer liver neoplasms than the nitrosohydroxyethyl analog and only few kidney neoplasms. Both of these carcinogens were less effective in female rats than in males, although the females, which were smaller, received a higher dose per unit body weight. The spectrum of neoplasms induced by the nitrosohydroxyalkyl-chloroethylureas was quite different from that induced by equimolar doses of each corresponding nitrosohydroxyalkylurea, neither of which induced neoplasms of the liver, although they were potent inducers of neoplasms in other organs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3782261     DOI: 10.1007/bf00395916

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  7 in total

1.  Carcinogenesis in F344 rats by N-nitrosomethyl-n-propylamine derivatives.

Authors:  W Lijinsky; M D Reuber; J E Saavedra; G M Singer
Journal:  J Natl Cancer Inst       Date:  1983-05       Impact factor: 13.506

2.  Induction of liver tumors in rats by nitrosodiethanolamine at low doses.

Authors:  W Lijinsky; R M Kovatch
Journal:  Carcinogenesis       Date:  1985-12       Impact factor: 4.944

3.  Dose-response study with N-nitrosodiethanolamine in F344 rats.

Authors:  W Lijinsky; M D Reuber
Journal:  Food Chem Toxicol       Date:  1984-01       Impact factor: 6.023

4.  Carcinogenicity of hydroxylated alkylnitrosoureas and of nitrosooxazolidones by mouse skin painting and by gavage in rats.

Authors:  W Lijinsky; M D Reuber
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

5.  Similar carcinogenic effects in rats of 1-ethyl-1-nitroso-3-hydroxyethylurea and 1-hydroxyethyl-1-nitroso-3-ethylurea.

Authors:  W Lijinsky; G M Singer; R M Kovatch
Journal:  Carcinogenesis       Date:  1985-04       Impact factor: 4.944

6.  Carcinogenicity of chlorinated nitrosotrialkylureas in rats.

Authors:  W Lijinsky; H W Taylor
Journal:  J Cancer Res Clin Oncol       Date:  1979-06-08       Impact factor: 4.553

7.  Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential.

Authors:  G Eisenbrand; H H Fiebig; W J Zeller
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30
  7 in total
  3 in total

Review 1.  Structure-activity relations in carcinogenesis by N-nitroso compounds.

Authors:  W Lijinsky
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989.

Authors:  L S Gold; N B Manley; T H Slone; G B Garfinkel; L Rohrbach; B N Ames
Journal:  Environ Health Perspect       Date:  1993-04       Impact factor: 9.031

3.  Carcinogenesis by nitrosohydroxyethylurea and nitrosomethoxyethylurea in F344 rats.

Authors:  W Lijinsky; R M Kovatch
Journal:  Jpn J Cancer Res       Date:  1988-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.